ArticleJournal of orthopaedic surgery and research2026
3D bioprinted bilayer GelMA/HAp hydrogel scaffold functionalized with miR-140-5p-modified MSCs for enhanced osteochondral regeneration.
Article in Journal of orthopaedic surgery and research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundOsteochondral defects remain a major clinical challenge due to the limited intrinsic healing capacity of articular cartilage and the complex structural integration required between cartilage and subchondral bone. Tissue-engineered scaffolds offer a promising strategy for improving repair outcomes.
methodsWe developed a 3D bioprinted bilayer GelMA/hydroxyapatite (HAp) hydrogel scaffold incorporating miR-140-5p-modified mesenchymal stem cells (MSCs). The upper chondral-oriented layer consisted of 5% GelMA60, while the lower relatively stiffer HAp-containing layer comprised 5% GelMA90 with 1% HAp. Mechanical properties, cell viability, migration, and differentiation were evaluated in vitro. Osteochondral repair efficacy was further assessed in a rabbit femoral condyle defect model using macroscopic scoring, Micro-CT, and histological analysis.
resultsThe bilayer scaffold demonstrated enhanced compressive strength and maintained favorable swelling characteristics. MSC viability remained high in both scaffold groups and exceeded 90% by day 5 after bioprinting. miR-140-5p modification significantly promoted MSC migration and upregulated chondrogenic markers. In vivo, the functionalized scaffold markedly improved cartilage surface integrity, subchondral bone reconstruction, and ICRS scores compared with controls.
conclusionThe 3D bioprinted bilayer GelMA/HAp scaffold combined with miR-140-5p-modified MSCs significantly enhances osteochondral repair in a rabbit model and represents a promising strategy for clinical translation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.